Clinton taps 4 Indian drug firms
Former US president Bill Clinton has roped in four Indian and two Chinese pharmaceutical firms to cut the price of anti-malarial drugs by a whopping 30 per cent, which is likely to benefit 500 million people worldwide. The firms have also agreed to lower the price volatility of artemisinin, the key raw material for artemisinin-based combination therapy (ACT), by 70 per cent, said Clinton, whose charitable foundation helped broker the deal.